Related Experiment Video
Updated: Oct 3, 2025

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
Extreme prematurity: Risk and resiliency
Genevieve L Taylor1, T Michael O'Shea2
1Genevieve L Taylor MD: Department of Pediatrics, Division of Neonatal-Perinatal Medicine, University of North Carolina School of Medicine.
Insights
Infants born extremely preterm face higher risks of neurodevelopmental disorders. Interventions aim to prevent premature birth and improve outcomes for these vulnerable children.
Area of Science:
- Neonatal Medicine
- Developmental Pediatrics
- Public Health
Background:
- Extremely preterm birth (before 28 weeks) is rare but disproportionately affects children with neurodevelopmental disorders.
- Conditions include cerebral palsy, intellectual deficit, autism, ADHD, and epilepsy.
- This review focuses on two major cohorts: EPICURE (UK/Ireland) and ELGAN (US).
Purpose of the Study:
- To review neurodevelopmental outcomes in extremely preterm infants.
- To identify early life and prenatal risk factors.
- To summarize current interventions for improving life course outcomes.
Main Methods:
- Analysis of data from the EPICURE and ELGAN cohorts.
- Focus on neurodevelopmental disorders, growth, respiratory illness, and well-being.
- Examination of perinatal brain damage, bronchopulmonary dysplasia, inflammation, and socioeconomic factors.
Main Results:
- Extremely preterm infants have increased risks for most neurodevelopmental disorders.
- Perinatal factors (brain damage, BPD, inflammation) and prenatal socioeconomic position contribute to risk.
- Males face higher risks for adverse outcomes; neurodevelopmental impairment impacts quality of life.
Conclusions:
- Early life and prenatal factors significantly influence neurodevelopmental outcomes in extremely preterm infants.
- Interventions are crucial for preventing premature birth and mitigating adverse neurodevelopmental effects.
- Targeted postnatal support can improve the long-term life course for these individuals.
Abstract:
Individuals born extremely preterm (before 28 weeks of gestation) comprise only about 0.7% of births in the United States and an even lower proportion in other high resource countries. However, these individuals account for a disproportionate number of children with cerebral palsy, intellectual deficit, autism spectrum disorder, attention deficit hyperactivity disorder, and epilepsy. This review describes two large multiple center cohorts comprised of individuals born extremely preterm: the EPICURE cohort, recruited 1995 in the United Kingdom and the Republic of Ireland, and the Extremely Low Gestational Age Newborn (ELGAN), recruited 2002-2004 in five states in the United States. The primary focus of these studies has been neurodevelopmental disorders, but also of interest are growth, respiratory illness, and parent- and self-reported global health and well-being. Both of these studies indicate that among individuals born extremely preterm the risks of most neurodevelopmental disorders are increased. Early life factors that contribute to this risk include perinatal brain damage, some of which can be identified using neonatal head ultrasound, bronchopulmonary dysplasia, and neonatal systemic inflammation. Prenatal factors, particularly the family's socioeconomic position, also appear to contribute to risk. For most adverse outcomes, the risk is higher in males. Young adults born extremely preterm who have neurodevelopmental impairment, as compared to those without such impairment, rate their quality of life lower. However, young adults born extremely preterm who do not have neurodevelopmental impairments rate their quality of life as being similar to that of young adults born at term. Finally, we summarize the current state of interventions designed to improve the life course of extremely premature infants, with particular focus on efforts to prevent premature birth and on postnatal efforts to prevent adverse neurodevelopmental outcomes.
Related Concept Videos
Relative Risk
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-I
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...

